EUDA (EUDA Health Holdings) ROCE % : 0.00% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is EUDA Health Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EUDA Health Holdings's annualized ROCE % for the quarter that ended in Jun. 2024 was 0.00%.

EUDA Health Holdings ROCE % Historical Data

The historical data trend for EUDA Health Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EUDA Health Holdings ROCE % Chart

EUDA Health Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

712.58

EUDA Health Holdings Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial						-	-	-	-	-

EUDA Health Holdings ROCE % Calculation

EUDA Health Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-8.412	/	( ( (25.629 - 29.121)	+	(1.311 - 8.717) )	/ 2 )
	=	-8.412	/	( (-3.492	+	-7.406)	/ 2 )
	=	-8.412	/	-5.449
	=	154.38 %

EUDA Health Holdings's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	0	/	( ( (1.311 - 8.717)	+	(2.028 - 7.884) )	/ 2 )
	=	0	/	( ( -7.406	+	-5.856 )	/ 2 )
	=	0	/	-6.631
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

EUDA Health Holdings (NAS:EUDA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EUDA Health Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of EUDA Health Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

EUDA Health Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Pemimpin Drive No. 12-06, One Pemimpin, Singapore, SGP, 576151

Website

https://www.euda.com

EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.

Executives

Kongyew Wong	director	C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817
Chen Wei Wen Kelvin	director, officer: CHIEF EXECUTIVE OFFICER	C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Alfred Lim	director	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Kim Hing Chan	director	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
David Francis Capes	director	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Daniel Tan	officer: CHIEF TECHNOLOGY OFFICER	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Steven John Sobak	officer: CHIEF FINANCIAL OFFICER	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Lim Thien Su Gerald	director	C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Tan Meng Dong (james)	director, 10 percent owner, officer: Chief Executive Officer	UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000
Alexander K. Arrow	director	PO BOX 3094, REDWOOD CITY CA 94064
Kwong Yeow Liew	director	RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101
Yap Guan Hong William	director, officer: Chief Financial Officer	6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
Ajay Rajpal	director	6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
8i Holdings 2 Pte Ltd	10 percent owner	C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817